Supplementary Material-Safety and clinical response of TNF-α inhibitor adalimumab in the treatment of severe acne: A real-world study
Abstract
Supplementary Material for the paper "Safety and clinical response of TNF-α inhibitor adalimumab in the treatment of severe acne: A real-world study".
Fields of Study & Subjects
Acne and Rosacea Treatments and Effects
Dermatology and Skin Diseases
Dermatologic Treatments and Research
Publication details
- Journal / source
- Mendeley Data
- Publication date
- 19 January 2026